An Old Drug With A New Purpose

By ·
An Old Drug With A New Purpose featured image

Almost 40 years ago, a vertigo drug called Betahistine was taken off the U.S. market when the FDA began demanding more clinical trials on all medications and the manufacturer simply didn’t comply. Fast-forward to the new century, and an Israeli physician has discovered there may be a reason to bring its formula back.

Nir Barak knew that blocking the brain’s histamine-1 receptor causes weight gain, and that stimulating it should do the opposite. He found that Betahistine had this function and that it was inherently safe.

His company, Obecure, conducted double-blind clinical trials and, as the August issue of Business 2.0 reports, the unofficial results are impressive: participants lost up to 12% of their body weight with no side effects. They simply didn’t crave food as much-especially fatty foods.

This wouldn’t be the first time a drug with one purpose has been redirected for another. The ulcer medication known as Tagamet would cause unwanted hair growth in its users, but it would cause very-much-wanted hair growth in what would become Rogaine users.

Find a Doctor

Find a NewBeauty "Top Beauty Doctor" Near you

Give the Gift of Luxury

NewBeauty uses cookies for various reasons, including to analyze and improve its content and advertising. Please review our Privacy Policy and Terms of Use for more about how we use this data. By continuing to use this site, you agree to these policies.